Authors
Mannick, Joan B.UMass Chan Affiliations
Department of Medicine, Division of Infectious Diseases and ImmunologyDocument Type
Journal ArticlePublication Date
2006-03-28Keywords
Administration, InhalationAnimals
Anti-Bacterial Agents
Apoptosis
Bacterial Infections
Humans
Interleukins
Lymphocyte Activation
Nitric Oxide
Life Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
The therapeutic effects of inhaled nitric oxide (NO) therapy are thought to be restricted to the pulmonary vasculature because of rapid inactivation of NO by hemoglobin in the bloodstream. However, recent data suggest that inhaled NO may not only be scavenged by the heme iron of hemoglobin but also may react with protein thiols in the bloodstream, including cysteine-93 of the hemoglobin B subunit. Reaction of NO with protein or peptide thiols is termed S-nitrosylation and results in the formation of relatively stable protein S-nitrosothiols that carry NO bioactivity to distal organs. Thus, inhaled NO-induced protein S-nitrosylation may allow inhaled NO to have multiple as yet undiscovered physiologic and pathophysiologic effects outside of the lung. Here we review the immunoregulatory and antimicrobial functions of NO and the potential effects of inhaled NO therapy on host defense.Source
Proc Am Thorac Soc. 2006 Apr;3(2):161-5. Link to article on publisher's site
DOI
10.1513/pats.200505-048BGPermanent Link to this Item
http://hdl.handle.net/20.500.14038/38911PubMed ID
16565425Related Resources
ae974a485f413a2113503eed53cd6c53
10.1513/pats.200505-048BG